Patents by Inventor Edward E. Cable

Edward E. Cable has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment of intestinal barrier dysfunction and associated diseases
    Publication number: 20210145775
    Abstract: Treatment of intestinal barrier dysfunction and associated diseases other than alcoholic liver disease or NAFLD/NASH with seladelpar or a salt thereof.
    Type: Application
    Filed: November 12, 2020
    Publication date: May 20, 2021
    Applicant: CymaBay Therapeutics, Inc.
    Inventor: Edward E. Cable
  • Treatment of alcoholic liver disease
    Publication number: 20210145774
    Abstract: Treatment of alcoholic liver disease with seladelpar or a salt thereof.
    Type: Application
    Filed: November 12, 2020
    Publication date: May 20, 2021
    Applicant: CymaBay Therapeutics, Inc.
    Inventor: Edward E. Cable
  • Thyromimetics for the treatment of fatty liver diseases
    Patent number: 10925885
    Abstract: The present invention is directed toward the use of thyromimetic compounds that are thyroid receptor ligands, pharmaceutically acceptable salts thereof, and to prodrugs of these compounds for preventing, treating, or ameliorating fatty liver diseases such as steatosis, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis.
    Type: Grant
    Filed: November 19, 2018
    Date of Patent: February 23, 2021
    Assignee: Metabasis Therapeutics, Inc.
    Inventors: Edward E. Cable, Mark D. Erion
  • THYROMIMETICS FOR THE TREATMENT OF FATTY LIVER DISEASES
    Publication number: 20190083515
    Abstract: The present invention is directed toward the use of thyromimetic compounds that are thyroid receptor ligands, pharmaceutically acceptable salts thereof; and to prodrugs of these compounds for preventing, treating, or ameliorating fatty liver diseases such as steatosis, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis.
    Type: Application
    Filed: November 19, 2018
    Publication date: March 21, 2019
    Inventors: Edward E. Cable, Mark D. Erion
  • Thyromimetics for the treatment of fatty liver diseases
    Patent number: 10130643
    Abstract: The present invention is directed toward the use of thyromimetic compounds that are thyroid receptor ligands, pharmaceutically acceptable salts thereof, and to prodrugs of these compounds for preventing, treating, or ameliorating fatty liver diseases such as steatosis, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis.
    Type: Grant
    Filed: November 29, 2010
    Date of Patent: November 20, 2018
    Assignee: Metabasis Therapeutics, Inc.
    Inventors: Edward E. Cable, Mark D. Erion
  • Thyromimetics for the Treatment of Fatty Liver Diseases
    Publication number: 20170112864
    Abstract: The present invention is directed toward the use of thyromimetic compounds that are thyroid receptor ligands, pharmaceutically acceptable salts thereof, and to prodrugs of these compounds for preventing, treating, or ameliorating fatty liver diseases such as steatosis, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis.
    Type: Application
    Filed: November 29, 2010
    Publication date: April 27, 2017
    Applicant: METABASIS THERAPEUTICS, INC.
    Inventors: Edward E. CABLE, Mark D. ERION
  • Thyromimetics for the Treatment of Fatty Liver Diseases
    Publication number: 20090232879
    Abstract: The present invention is directed toward the use of thyromimetic compounds that are thyroid receptor ligands, pharmaceutically acceptable salts thereof, and to prodrugs of these compounds for preventing, treating, or ameliorating fatty liver diseases such as steatosis, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis.
    Type: Application
    Filed: May 26, 2006
    Publication date: September 17, 2009
    Applicant: Metabasis Therapeutics, Inc.
    Inventors: Edward E. Cable, Mark D. Erion